Melbourne scientists have shown for the first time how a “revolutionary” blood cancer treatment could be tweaked to also cure ...

CRISPR is revolutionizing medicine by enabling precise DNA edits, treating genetic diseases like sickle cell anemia and ...

New research has found a novel target with therapeutic potential for metastatic eye melanoma—an aggressive eye cancer—with ...

“By uncovering specific genetic vulnerabilities like the CDS1 and CDS2 relationship, we’re opening the door to new therapies ...

Scientists at Fox Chase Cancer Center have identified a mutation in a common oncogene—a gene that can cause cancer—that may ...

University of Cincinnati Cancer Center researchers looked billions of years into the past to learn more about the potential ...

Cambridge-driven research has identified a novel target with therapeutic potential for metastatic eye melanoma — an ...

CRISPR technology is transforming modern medicine by enabling precise DNA editing to treat genetic disorders, including sickle cell anemia and beta-thalassemia, experts say.

In a step toward treating mitochondrial diseases, researchers in the Netherlands have successfully edited harmful mutations ...

Landmark research on MCL-1, a critical protein that is an attractive target for cancer drug development, helps explain why ...

Cancer research no longer moves slowly; it advances rapidly. Revolutionary discoveries in precision medicine, immunotherapy, ...